Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Microbial Pathogenesis|November 19, 2025
Nucleoside diphosphate kinase (LdNDK2): A metacyclogenesis-regulating kinase essential for Leishmania parasite survival within eukaryotic host cellsAnkit Gupta, Mirza Adil Beg, Surbhi Badhwar, et al.
Drug Metabolism Letters|November 28, 2014
A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 modelDevang Shah, Sundeep Paruchury, Muralikrishna Matta, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|May 26, 2018
A novel signal sequence negative multimeric glycosomal protein required for cell cycle progression of Leishmania donovani parasitesKavita Ahuja, Mirza Adil Beg, Ruby Sharma, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 26, 2017
Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discoveryMichael Morgen, Ajay Saxena, Xue-Qing Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2016
Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing ActivityShailesh Dudhgaonkar, Sourabh Ranade, Jignesh Nagar, et al.
Journal of Medicinal Chemistry|April 19, 2017
Selective IKur Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamidePrashantha Gunaga, John Lloyd, Somanadham Mummadi, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of PsoriasisSatheesh Nair, Sreekantha Ratna Kumar, Venkatram Reddy Paidi, et al.
Pageof 2